Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
63,641.05 +820.84 (+1.31%) CMC Crypto 200
1,323.81 +46.83 (+3.67%)
Verve Therapeutics, Inc. (VERV)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 6.15 |
| Open | 6.43 |
| Bid | 6.38 x 300 |
| Ask | 6.42 x 200 |
| Day's range | 6.28 - 7.00 |
| 52-week range | 5.84 - 21.42 |
| Volume | |
| Avg. volume | 1,316,438 |
| Market cap | 537.945M |
| Beta (5Y monthly) | 1.70 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.12 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 32.13 |
GlobeNewswireVerve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BOSTON, May 03, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced that on April 30, 2024, the company granted equity awards to ten new employees, pursuant to the company’s 2024 Inducement Stock Incentive Plan, as an inducement material to each new employee entering into employment with the company in accordance with Nasdaq Listing Rule 5635(
ZacksWhy Investors Need to Take Advantage of These 2 Medical Stocks Now
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
ZacksBiotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More
Disc Medicine, Inc. (IRON) and Verve Therapeutics (VERV) fall on study updates.
© 2024 Yahoo. All rights reserved.